Theravance Biopharma (TBPH) has the following price history information. Looking back at TBPH historical stock prices for the last five trading days, on April 29, 2024, TBPH opened at $9.14, traded as high as $9.22 and as low as $8.95, and closed at $8.99. Trading volume was a total of 293.20K shares. On April 30, 2024, TBPH opened at $8.98, traded as high as $8.98 and as low as $8.42, and closed at $8.44. Trading volume was a total of 368.60K shares. On May 01, 2024, TBPH opened at $8.44, traded as high as $8.98 and as low as $8.40, and closed at $8.84. Trading volume was a total of 2.06M shares. On May 02, 2024, TBPH opened at $8.90, traded as high as $9.38 and as low as $8.88, and closed at $9.37. Trading volume was a total of 455.30K shares. On May 03, 2024, TBPH opened at $9.48, traded as high as $9.62 and as low as $9.29, and closed at $9.46. Trading volume was a total of 333.60K shares.

TBPH Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Theravance Biopharma shares, starting with a $10,000 purchase of TBPH, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	05/19/2014
End date:	05/03/2024
Start price/share:	$21.97
End price/share:	$9.46
Dividends collected/share:	$0.00
Total return:	-56.94%
Average Annual Total Return:	-8.11%
Starting investment:	$10,000.00
Ending investment:	$4,305.17
Years:	9.96

TBPH Historical Price Range
Date	Open	High	Low	Close	Volume
04/29/2024	$9.14	$9.22	$8.95	$8.99	293.20K
04/30/2024	$8.98	$8.98	$8.42	$8.44	368.60K
05/01/2024	$8.44	$8.98	$8.40	$8.84	2.06M
05/02/2024	$8.90	$9.38	$8.88	$9.37	455.30K
05/03/2024	$9.48	$9.62	$9.29	$9.46	333.60K

About Theravance Biopharma

Theravance Biopharma is a biopharmaceutical company primarily focused on the discovery, development and commercialization of respiratory medicine medicines. Co.'s program include: YUPELRI™ (revefenacin) inhalation solution, nebulized long-acting muscarinic antagonist for the maintenance treatment of chronic obstructive pulmonary disease; and Lung-selective, Nebulized Pan-Janus Kinase (JAK) Inhibitor (Nezulcitinib), a lung-selective, nebulized JAK inhibitor, in clinical development for the potential treatment of hospitalized patients with acute lung injury caused by Coronavirus Disease 2019.

TBPH Historical Closing Prices
Date	Close
04/29/2024	$8.99
04/30/2024	$8.44
05/01/2024	$8.84
05/02/2024	$9.37
05/03/2024	$9.46

TBPH Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.